{
  "thread": {
    "uuid": "66f059cbd7de2fb83a095cc79dcbb493b519156a",
    "url": "https://www.lelezard.com/en/news-21568790.html",
    "site_full": "www.lelezard.com",
    "site": "lelezard.com",
    "site_section": "https://www.lelezard.com/en/news-rss/all",
    "site_categories": [
      "canada",
      "travel"
    ],
    "section_title": "Le LÃ©zard : All news",
    "title": "Acute Ischemic Stroke Therapeutics Market to Grow by USD 1.74 Billion from 2024-2028, Driven by Rising Cardiovascular Disease Prevalence and AI-Driven Market Transformation - Technavio",
    "title_full": "Acute Ischemic Stroke Therapeutics Market to Grow by USD 1.74 Billion from 2024-2028, Driven by Rising Cardiovascular Disease Prevalence and AI-Driven Market Transformation - Technavio",
    "published": "2024-10-17T21:20:00.000+03:00",
    "replies_count": 0,
    "participants_count": 0,
    "site_type": "news",
    "country": "CA",
    "main_image": "",
    "performance_score": 0,
    "domain_rank": 95649,
    "domain_rank_updated": "2024-10-15T00:00:00.000+03:00",
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "66f059cbd7de2fb83a095cc79dcbb493b519156a",
  "url": "https://www.lelezard.com/en/news-21568790.html",
  "ord_in_thread": 0,
  "parent_url": null,
  "author": null,
  "published": "2024-10-17T21:20:00.000+03:00",
  "title": "Acute Ischemic Stroke Therapeutics Market to Grow by USD 1.74 Billion from 2024-2028, Driven by Rising Cardiovascular Disease Prevalence and AI-Driven Market Transformation - Technavio",
  "text": "Classified in: Health\nSubject: MRR Acute Ischemic Stroke Therapeutics Market to Grow by USD 1.74 Billion from 2024-2028, Driven by Rising Cardiovascular Disease Prevalence and AI-Driven Market Transformation - Technavio\nNEW YORK , Oct. 17, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The Global Acute Ischemic Stroke Therapeutics Market size is estimated to grow by USD 1.74 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 6.1% during the forecast period.Rising prevalence of cardiovascular diseases is driving market growth, with a trend towards integrating genomic and clinical data through translational bioinformatics in acute ischemic stroke management. However, unmet needs for anticoagulant reversal agents poses a challenge - Key market players include Amgen Inc., AstraZeneca Plc, Athersys Inc., Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., F. Hoffmann La Roche Ltd., Johnson and Johnson Services Inc., Medtronic PLC, Merck and Co. Inc., NoNO Inc., Pfizer Inc., SanBio Co. Ltd., Sanofi SA, Stryker Corp., and Teva Pharmaceutical Industries Ltd..\nKey insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View the snapshot of this report",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "english",
  "sentiment": "positive",
  "categories": [
    "Health",
    "Economy, Business and Finance",
    "Science and Technology"
  ],
  "ai_allow": true,
  "webz_reporter": false,
  "external_links": [
    "https://analysis.technavio.org/cardiovascular-market-analysis",
    "https://www.businesswire.com/news/home/20201009005283/en/Genomics-Market-Need-for-CreatingUpgrading-Genome-Databases-to-Boost-the-Market-Growth-Technavio",
    "https://www.technavio.com/report/acute-ischemic-stroke-therapeutics-market-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=ai_trend_v2_report_week42_2024&utm_content=IRTNTR45749",
    "https://www.businesswire.com/news/home/20170301005087/en/Increase-in-Lifestyle-Diseases-to-Boost-the-Global-Anticoagulant-Market-Through-2021-Reports-Technavio",
    "https://mma.prnewswire.com/media/2532820/IRTNTR45749_bw_info_v4.html",
    "https://businesswire.com/news/home/20170301005087/en/Increase-in-Lifestyle-Diseases-to-Boost-the-Global-Anticoagulant-Market-Through-2021-Reports-Technavio",
    "https://www.mma.prnewswire.com/media/2532820/IRTNTR45749_bw_info_v4.html",
    "https://technavio.com/report/acute-ischemic-stroke-therapeutics-market-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=ai_trend_v2_report_week42_2024&utm_content=IRTNTR45749",
    "https://www.technavio.com/report/acute-ischemic-stroke-therapeutics-market-industry-analysis",
    "https://www.analysis.technavio.org/cardiovascular-market-analysis",
    "https://businesswire.com/news/home/20201009005283/en/Genomics-Market-Need-for-CreatingUpgrading-Genome-Databases-to-Boost-the-Market-Growth-Technavio"
  ],
  "external_images": [],
  "entities": {
    "persons": [
      {
        "name": "Johnson",
        "sentiment": "none"
      }
    ],
    "organizations": [
      {
        "name": "Boehringer Ingelheim International GmbH",
        "sentiment": "none"
      },
      {
        "name": "Bristol Myers Squibb Co.",
        "sentiment": "none"
      },
      {
        "name": "Daiichi Sankyo Co. Ltd.",
        "sentiment": "none"
      },
      {
        "name": "Johnson Services Inc.",
        "sentiment": "none"
      },
      {
        "name": "AstraZeneca Plc",
        "sentiment": "none"
      },
      {
        "name": "Athersys Inc.",
        "sentiment": "none"
      },
      {
        "name": "Medtronic PLC",
        "sentiment": "none"
      },
      {
        "name": "Biogen Inc.",
        "sentiment": "none"
      },
      {
        "name": "Amgen Inc.",
        "sentiment": "none"
      },
      {
        "name": "NoNO Inc.",
        "sentiment": "none"
      },
      {
        "name": "Bayer AG",
        "sentiment": "none"
      }
    ],
    "locations": []
  },
  "syndication": {
    "syndicated": false,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "rating": null,
  "crawled": "2024-10-18T02:41:10.232+03:00",
  "updated": "2024-10-18T02:41:10.232+03:00"
}